Randomized trials have demonstrated that primary angioplasty is more effective than intravenous thrombolysis in reducing mortality and morbidity in patients with acute myocardial infarction (AMI). The aim of this study was to assess the in-hospital mortality of patients with AMI admitted to the only tertiary care center in Kosovo, where coronary percutaneous intervention procedures are unavailable. We also assessed the impact of age and gender on in-hospital mortality.
I n general, clinical presentation and outcome of acute myocardial infarction (AMI) and coronary artery disease vary across regions and differ from country to country. 1 Significant differences in the prevalence of AMI exist with respect to gender, age and ethnicity.
1 Despite major progress in prevention, diagnosis, and treatment, coronary artery disease is the leading cause of mortality in the general populat t tion.
2 Several studies have shown that in patients with AMI, age 70 years or older is clinically important and an independent predictor of increased risk of inthospit t tal death. 3t6 Most previous studies demonstrated that women have a higher inthospital mortality than men. The reduced mortality of pat t tients with AMI in recent years, compared with previt t ous decades, may be explained at least in part by more widespread use of percutaneous coronary intervention such as a revascularization approach. 16, 17 The aim of this study was to assess the inthospital mortality of patients with AMI from the Kosovo population adt t mitted in the only tertiary health center in Kosovo, which is also the secondary health center for more than 1 million inhabitants of Prishtina. The other obt t jective of our study was to assess the impact of age and gender on inthospital mortality in these patients.
PATIENTS AND METHODS
This study included 2848 consecutive patients with a clinical diagnosis of AMI at discharge or death due to AMI managed in the coronary care unit and two divit t sions of cardiology in the Service of Cardiology, at the Internal Medicine Clinic, University Clinical Center of Kosovo, in Prishtina, between June 1999 and May 2007. The inclusion criterion for this study was the diagnosis of AMI established according the definition of the World Health Organization, which requires at least two of the following criteria: (1) typical chest pain that lasted for ≥20 minutes; (2) typical changes on surface ECG (STtsegment elevation of ≥0.1 mV in ≥2 limb leads or ≥0.2 mV in ≥2 contiguous pret t cordial leads, pathological Q waves, or complete left bundle branch block of new onset); and (3) increased activity of creatine kinase (CK) and/or its myocardial band (CKtMB) ≥two times the upper limit of normal range.
8 Trained research medical students studied the information from the hospital medical records in the hospital archive. Demographic data were obtained from all patients including age, gender, laboratory data, ECG, and the prevalence of risk factors such as a previous hist t tory of coronary heart disease, diabetes, hypertension, smoking status, family history of cardiovascular disease and clinical course during hospitalization.
Based on the review of all inthospital ECGs, AMI was classified as either Qtwave infarction or nontQt wave infarction. Regarding infarct location, AMI was classified as anterior (septal, anterolateral, high lateral, extensive anterior) if electrocardiographic changes dit t agnostic of AMI involved the following leads: D1, aVL, V1tV3; V4tV6), inferior (inferior, inferolateral, inferodorsal, laterodorsal, inferolaterodorsal) if electrot t cardiographic changes diagnostic of AMI involved the following leads: D2, D3, AVF; D1, AVL; V5 and V6; V7 and V8) and anteroinferior when the ECG changes involved leads from both above locations. Information on diabetes, hypertension, smoking status and a famt t ily history of cardiovascular disease was extracted from medical records. Hypercholesterolemia was diagnosed if total cholesterol was >5 mmol/L or if patient received lipidtlowering therapy. Patients were divided into three categories: ≤45 years (young), >45 to 65 years (middle age), and >65 years (old age).
Data are presented as mean±standard deviation or proportions (% of patients). Continuous data were compared with the twottailed unpaired t test and with onetway ANOVA. Discrete data were compared with the chitsquare test. A P value <.05 was considered to indicate statistical significance.
RESULTS
The mean age of the study population was 61.0±11.3 years (Table 1) . Of 2848 patients with AMI, 1254 (44%) had arterial hypertension, 541 (19%) had diat t betes mellitus, 627 (22%) had hypercholesterolemia, 1538 (54%) had smoked (current or extsmokers) prior to admission and 1542 had a positive familial history for coronary artery disease. There were 2091 (73.4%) males and 757 (26.6%) females. The female patients were significantly older than male patients (64.2±11 years vs. 59.7±11.8 years, P<.001), and the risk factor profile differed significantly between female and male patients (Table 2) . A positive family history for corot t nary artery disease was the most important risk fact t tor for females (67.2%) compared with males (49.4%) (P<.001). Hypercholesterolemia was more frequent in females (30.4%) than in males (19%, P<.001). On the other hand, smoking (66.5%) and hypertension (47.8%) were significantly more frequent in males. The proport t tion of patients with diabetes did not differ significantly between males and females. Anterior wall infarction occurred in 1595 patients (56%), inferior wall infarction in 1196 (42%), and ant t teroinferior infarction in 57 (2%). During the inthost t pital stay, 292 (10.3%) patients died and 2556 patients were discharged from the hospital after a mean stay of 11±8 days. The overall inthospital mortality was 12.3% for women and 9.5% for men (P<.05) ( Table 1) . (Figure  1 ) from 58.8 years to 62.4 years (P=.018). The mortalt t ity rate seems not to have decreased during the same years ( Figure 2 ).
DISCUSSION
One of the main findings of our study was that the age of patients admitted for AMI in Kosovo was lower than the age of patients in most European countries. 11,17t20 This finding may be explained by the higher prevalence of important risk factors, such as smoking and a positive family history for coronary artery disease in our patients. In fact, the prevalence of smoking in our study population is among the highest in Europe. We found that women were of older age than men at the time of AMI. This finding is in accordance with previous studies. 8t11,19t21 Furthermore, the inthospital stay was longer and mortality among our patients was higher compared with developed countries. 9, 16, 19, 21, 23, 24 This may be explained by the lack of early revasculart t ization interventional therapy.
The mortality in patients treated with thrombolysis in the MITRA/MIR (Maximal Individual Therapy in the Acute Myocardial Infarction Registry) 16 was similar to our findings, but the patients treated with angioplast t ty showed lower mortality. Therefore, the unavailability of the angioplasty procedure in our center could have had an important negative impact on observed hight rates of inthospital mortality. In addition, though not analyzed in this study, possible delays in arrival of pat t tients in our center, due to the lack of a system of early health care delivery to those patients, have taken their toll on mortality as well. The mortality rate, however, was lower than in some studies conducted over the last decade, 8,10,22 which may imply that the treatment of our patients is in accordance with recommended protocols that include thrombolysis.
Our study demonstrated that women with AMI have a significantly higher inthospital mortality rate than men. This finding is in accordance with previous studies.
8t11 ,20,21,23,24 However,Hirakawa et al 19 in the sett t ting of the Tokai Acute Myocardial Infarction Study II (TAMIS II) study found that women with AMI undert t going percutaneous interventions in AMI did not have a significantly higher inthospital mortality rate compared to men in Japan. In particular, we found that the mortalt t ity rate was significantly higher for female patients comt t pared with male patients of a younger age, but not in the other two older age groups. This finding is in accort t dance with the findings of a study by Vaccarino et al, 22 but it contradicts findings of a study by Fabijanic et al, 10 who found a significantly higher mortality rate in fet t male patients >65 years, whereas in patients <65 years there were no significant differences. Previous studies of myocardial infarction in elderly patients found either no significant differences in the mortality rate between men and women 25, 26 or a lower rate among women.
27,28
Our study has several limitations. First, only inthost t pital patient outcomes were analyzed; we have no infort t mation on prethospital deaths. In addition, we did not have the posttdischarge mortality data of these patients. Second, information about treatment with aspirin, betatblockers, ACE inhibitors, statins and thromolytic therapy was not collected, although these medications were routinely used in our patients. These treatments have been proven to reduce mortality in AMI patients. 29 Third, we could not assess the cause except by clinical and ECG data as autopsies were not performed.
In conclusion, the age of AMI patients in Kosovo is lower than in developed countries. The inthospital stay was longer and inthospital mortality was higher comt t pared to developed countries. Our study demonstrates that women with AMI have significantly higher inthost t pital mortality than men. It seems that that the lack of percutaneous coronary interventions in our patients with AMI may have contributed to the high inthospital mortality. 
